Part B Drugs – Page 2 – MedPAC

An official website of the United States Government —

Here’s how you know

MedPAC > Our Work > Part B Drugs

Part B Drugs

Showing 11 - 20 out of 194

Sep 12, 2022 / Comment Letters

MedPAC comment on CMS’s proposed rule on the payment systems for hospital outpatient departments and ambulatory surgical centers for 2023

Research Areas:

Ambulatory Care Settings, Drugs, Devices, and Tests, Hospitals, Quality, Regional Issues

Sep 02, 2022 / Comment Letters

MedPAC comment on CMS’s proposed rule on CY 2023 revisions to payment policies under the physician fee schedule and other changes to Part B payment policies

Research Areas:

Delivery System Reforms, Drugs, Devices, and Tests, Physicians And Other Health Professionals, Quality

Sep 01, 2022 / Transcripts

September 1-2, 2022 meeting transcript

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests, Medicare Spending and Financing, Physicians And Other Health Professionals, Private Plans, Quality

Sep 01, 2022 / Presentations

Addressing high prices of drugs covered under Medicare Part B

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing

Jun 15, 2022 / Reports

June 2022 Report to the Congress: Medicare and the Health Care Delivery System

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2022 / Chapters

Executive summary (June 2022 report)

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2022 / Chapters

Chapter 4: Addressing high prices of drugs covered under Medicare Part B (June 2022 report)

Research Areas:

Drugs, Devices, and Tests

Jun 15, 2022 / Chapters

Appendix A: Commissioners’ voting on recommendations (June 2022 report)

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Private Plans, Quality, Regional Issues

Jun 15, 2022 / Press Releases

MedPAC releases June 2022 Report to the Congress: Medicare and the Health Care Delivery System

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Private Plans, Quality, Regional Issues